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Abstract
Severe hyperbilirubinemia causes neurological damage both in humans and rodents. The hyperbilirubinemic Gunn
rat shows a marked cerebellar hypoplasia. More recently bilirubin ability to arrest the cell cycle progression in
vascular smooth muscle, tumour cells, and, more importantly, cultured neurons has been demonstrated. However,
the involvement of cell cycle perturbation in the development of cerebellar hypoplasia was never investigated before.
We explored the effect of sustained spontaneous hyperbilirubinemia on cell cycle progression and apoptosis in whole
cerebella dissected from 9 day old Gunn rat by Real Time PCR, Western blot and FACS analysis. The cerebellum of
the hyperbilirubinemic Gunn rats exhibits an increased cell cycle arrest in the late G0/G1 phase (p < 0.001),
characterized by a decrease in the protein expression of cyclin D1 (15%, p < 0.05), cyclin A/A1 (20 and 30%, p <
0.05 and 0.01, respectively) and cyclin dependent kinases2 (25%, p < 0.001). This was associated with a marked
increase in the 18 kDa fragment of cyclin E (67%, p < 0.001) which amplifies the apoptotic pathway. In line with this
was the increase of the cleaved form of Poly (ADP-ribose) polymerase (54%, p < 0.01) and active Caspase3 (two
fold, p < 0.01). These data indicate that the characteristic cerebellar alteration in this developing brain structure of the
hyperbilirubinemic Gunn rat may be partly due to cell cycle perturbation and apoptosis related to the high bilirubin
concentration in cerebellar tissue mainly affecting granular cells. These two phenomena might be intimately
connected.
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Introduction
Crigler-Najjar Syndrome type I (CNI) is a rare deficiency of
bilirubin UDP-glucuronosyl-transferase 1A1 (UGT1A1) activity
caused by mutations of the UGT1A1 gene[1,2]. The inability to
effectively conjugate unconjugated bilirubin (UCB), results in
massive deposition of the pigment in tissues, notably causing
neuronal loss in selected structures of the central nervous
system early in infancy [3–5].
The homozygous (jj) hyperbilirubinemic Gunn rat [6],
manifest an inherited absence of the UDP-glucuronosyl-
transferase (Ugt1a1) enzyme activity, due to a spontaneous
point mutation in the Ugt1a1 gene, leading to a truncated-
inactive protein. With similar (to humans) inability to effectively
conjugate and excrete bilirubin and central neurological
damage, it has been used as an animal model of CNI and
neonatal jaundice [7–9]. In jj Gunn rats, a statistically significant
arrest in cerebellar growth develops by postnatal day 9 [10],
with prominent loss and degeneration of Purkinje cells and
granule neurons, impairment of myelinisation, arborisation and
synaptogenesis, and reduction in the molecular and external
granular cell layer thickness [11–17]. Similar findings of
bilirubin toxicity to cerebellum have been documented also in
humans [3,18,19].
UCB is believed to induce damage by altering membrane
permeability and transport [20], inducing mitochondrial energy
failure [21], and increasing intracellular calcium concentration
[22]. These effects are believed to trigger excitotoxicity, redox
state imbalance, inflammation and activate apoptosis/necrosis
of cells [21,23–26]. Similarly, hyperbilirubinemia has been
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associated with reduced cholesterol concentrations [27–29].
The brain contein about the 25% of the total body cholesterol,
mostly “entrapped” in the myelin (70-80%), and cellular
membranes (50-90%) [30]. Cholesterol biosynthesis is needed
for myelin production by oligodendrocytes, and recently
oligodendrocytes have emerged as the brain cellular population
most sensitive to bilirubin toxicity. The altered myelination
reported both in the Gunn rat and humans [15,17,18] are in line
with the alteration in cholesterol metabolism .
Recently, the high concentration of plasma bilirubin of jj
Gunn rat hasbeen associated with the suppression of vascular
neointima hyperplasia after balloon injury [31–33] and inhibition
of tumour growth [34,35]. In vitro treatment of primary cultures
and tumoral cell lines with UCB (or its precursor, biliverdin)
caused cell cycle arrest in the G1 phase, due to a decrease of
Cyclin D, E, A as well as Cdk2 protein [31–36]. Most
importantly, perturbation of the cell cycle by bilirubin exposure
has been documented in neuronal cells in vitro [37].
The macroscopic effect of bilirubin toxicity (hypoplasia) in the
brain of the Gunn rat occurs in the cerebellum [10], a CNS
structure rapidly developing early after. At this time,
proliferation of granular precursor cells localized in the external
granular layer, is the dominant event in the cerebellar growth
[38,39], making this structure an ideal target for bilirubin
toxicity. Functional and morphological findings of bilirubin
toxicity to cerebellum have also been documented in humans
[3,18,19,40], suggesting the validity of the Gunn rat model in
newborn jaundice.
The current study explores in vivo a possible links between
hyperbilirubinemia, cell cycle perturbation and apoptosis, in
relation to the cerebellar hypoplasia of jj Gunn rat pups, as
model for the human pathology. Cerebellar tissue of jaundiced
(jj) pups and their non-jaundiced (JJ) littermates were
compared at post-natal day 9, just at the onset of cerebellar
growth arrest in the jj rats.
Materials & Methods
Animals
Animals (of both sexes) were obtained from the animal
facility of the Department of Life Sciences of Trieste University.
Animal care and procedures were conducted according to the
Italian Law (decree 116-92) and to The European Communities
Council Directive 2010/63/EU. The project was approved by
the Local Ethical Committee of the Trieste University (protocol
no: 387 –II/9). Because animals spontaneously develop the
pathology, and no treatments have been applied, additional
ethical approval was not required. All efforts were made to
minimize the number of animals and their suffering.
Hyperbilirubinemic Gunn rats (jj) and normobilirubinemic wild-
type (JJ) were sacrificed 9 days after birth (P9) by decapitation
under (isofluorane) anaesthesia.
As previously shown by us [10] and others [13], at P9 the
cerebellar hypoplasia in Gunn pups is just starting to be
appreciable. Only thereafter the slope of growth curve and the
cerebellar weight diverge from those of normobilirubinemic
littermates indicating that cell death is the major phenomena
occurring after P9 to account for cerebellar hypoplasia. For this
reason, this post natal stage (P9) was considered the more
suitable stage to study the presence both cell cycle
perturbation and cell death. The cerebellum was immediately
removed and cleaned of meninges and 4th ventricle choroid
plexus. In addition cell cycle was evaluated also on the
cerebral cortex (a post mitotic CNS region after the birth),
dissected from normo-bilirubinemic (JJ) and hyperbilirubinemic
(jj) P9 Gunn rats (4 animals each genotype) after cleaning of
meninges and lateral ventricle choroid plexuses.
Bilirubin quantification in plasma and cerebella
Total bilirubin was quantified in plasma by the diazo-reaction
method [41] and unconjugated bilirubin (UCB) in whole
cerebella by the method developed by Zelenka [42]. Data are
expressed as mean ± SD of 6 independent biological
repetitions.
RNA isolation and real-time PCR analysis
Each hemi-cerebellum (9 animals each genotype. Each
animal was individually analysed) was collected in TriReagent
(Sigma-Aldrich, St Louis, MO, USA), and total RNA isolated
following the manufacturer’s instructions. Retro-transcription of
total RNA (1 μg) was performed with an iScriptTM cDNA
Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA)
according to the manufacturer’s instructions.
The primers for the targeted genes Cyclin D1, E1, A, A1 and
Cdk2, selected because reported as modulated by bilirubin
[31,32] and the two house-keeping genes (hypoxanthine-
guanine phosphoribosyltransferase: Hprt1 and glyceraldehyde
3-phosphate dehydrogenase: Gapdh) were designed using
Beacon Designer 8.10 software (PREMIER Biosoft
International, Palo Alto, CA, USA) (Table 1). The quantitative
analysis of gene expression was performed by real-time PCR
on 25 ng of cDNA. The gene-specific sense and anti-sense
primers (usually 250 nM, 300 nM for Cyclin A1 primers) were
added with iQ SYBER Green Supermix in an i-Cycler iQ
thermocycler (Bio-Rad Laboratories, Hercules, CA, USA), the
reaction was performed as previously described [43]. The
relative quantification was made using the iCycler iQ software,
version 3.1 (Bio-Rad Laboratories, Hercules, CA, USA) by the
ΔΔCt method [44,45], taking into account the efficiencies of the
individual genes and normalizing the results to the two
housekeeping genes. The levels of mRNA were expressed
relative to a reference sample.
Protein isolation and quantification by Western blot
analysis
The other hemi-cerebellum (9 animals each genotype) was
used for protein analysis as previously described [43]. Total
protein content was determined by the bicinchoninic acid kit
(Procedure # TPRO 562, Sigma, St Louis, MO, USA). Proteins
(25 µg) were separated by SDS-PAGE on 10 or 12%
polyacrylamide gels and transferred at 100 V for 1 hr onto
PVDF membrane (0.2 µm; Whatman Schleicher & Schuell,
Dassel, Germany). PVDF membranes were saturated for 2hr in
blocking solution (4% non fat milk or bovine serum albumin in
T-TBS) and incubated overnight at 4°C with the appropriate
antibody (Table 2). Secondary anti-rabbit or anti-mouse HRP
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conjugated antibodies (P0448, 0.04 µg/ml, and P0260,
0.26µg/ml, Dako, Glostrup, Denmark) were used. Signal was
detected by chemiluminescence (Millipore, Billeria, MA, USA)
on X-ray films (BioMax Light, Kodak Rochester, NY, USA), and
protein expression obtained as previously described [46].
Differentially, the p18-Cyclin E, Parp-1 (116 kDa), cleaved
Parp1 (cParp-1, 89 kDa) and active Caspase-3 (cCasp3, 17
kDa) protein expression (Table 2), were obtained only by
normalization with the actin signal on 50 µg of protein. In both
cases, actin and targeted protein signals were developed on
the same PVDF membrane. The same procedure was applied
to the cerebral cortex samples.
Tissue dispersion and cell cycle analysis
Cell dispersal and fixation was performed on freshly
dissected cerebellum as previously described with minor
modifications [47,48] (additional 7 JJ and 9 jj Gunn pups).
Briefly, small pieces of the tissue were mechanically dispersed
by 100 µm and 40 µm nylon cell strainers (BD Falcon # 352560
and # 352540, BD Bioscience, Bedford, USA). After
centrifugation (310 g; 4°C; 6 min), the cells pellet were fixed by
adding 5 ml of cold (-20°C) 80% ethanol drop-wise under
constant gentle vortexing. Samples were incubated for 30 min
on ice and stored at -20°C until stained. Thus, cells were
stabilized at RT for ≈ 10 min. After two sequential
centrifugations (310g; RT; 6 min) the sediments were
resuspended in 1ml of staining solution in PBS containing 0.1%
v/v Triton X-100, 20 µg/ml propidium iodide (PI), and 0.2mg/ml
DNAse free RNaseA. Samples were incubated in dark for 30
min at RT and subjected to FACS analysis (cytometer BD
FACSCaliburTM; and CellQuest software, BD Biosciences, San
Jose´, CA). Data were collected for 10,000 events per sample.
Primary cultures generation
To identify the cell type primarily affected by bilirubin
(neuronal vs. glial), primary cultures of granular neurons and
astrocytes from freshly dissected Wistar rat cerebella (HanTM -
RccHanTM:WIST) were used (Ethical Committee of the Trieste
University, protocol no: 387 –II/9). Animals were sacrificed by
decapitation under isofluorane anaesthesia. The cerebellum
was immediately removed and cleaned of meninges and 4th
ventricle choroid plexus.
Cerebellar Astrocytes Primary Cultures were obtained
pooling the cerebella dissected from 6 P2 Wistar pups for each
biological repetition (5 biological repetitions), as described
previously by Booher [49]. Briefly, the dissected Cll were
collected in RT Dulbecco’s Modified Eagle Medium, low
glucose (DMEM; Invitrogen, Life Technologies Corporation,
Grand Island, NY) supplemented with 10 % heat-inactived
foetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO, USA)
and 50 µg/mL gentamycin (Sigma-Aldrich, St. Louis, MO, USA)
(astrocytes culture medium). After cutting into small pieces,
cells were mechanically dissociated by a 70 µm nylon cell
strainer (#352350, BD Biosciences, Corning Inc., Corning, NY,
USA) and 20 times pipetting through a 5 mL pipette. The
resulting cell suspension was seeded at 1.2 x 105 cells/mL in 6-
well plates, and incubated in astrocyte culture medium at 37°C,
Table 1. Sequence of PCR primers for real-time PCR and efficiency.
Gene Accession Number Forward Reverse Eff. (%)
Gapdh NM_017008.3 CTCTCTGCTCCTCCCTGTTC CACCGACCTTCACCATCTTG 100.0
Hprt1 NM_012583.2 AGACTGAAGAGCTACTGTAATGAC GGCTGTACTGCTTGACCAAG 102.5
Cyclin D1 NM_171992.4 AGCTGAGGCGTCCCAACC CAACCAGAATACACAAAGCCAACC 101.6
Cyclin E1 NM_001100821.1 CAGTCAGCCTTGGGATGATGATTC TCCTCCAGACCTCTTCTCTATTGC 98.6
Cdk2 NM_199501.1 CGGCAGGATTTTAGCAAGGTTGTG CAGGTGAAGAGGGCTTTGGGAAG 98.0
Cyclin A1 NM_001011949.1 TATCTTCCTTCCTTGGTAG TAATGAATAGCCCGTAAATG 106.6
Cyclin A2 NM_053702.3 TAGATGCTGACCCATACC TCCTGTGACTGTGTAGAG 94.9
doi: 10.1371/journal.pone.0079073.t001
Table 2. Antibodies used for Western blotting.
 Blocking Solution Concentration (µg/mL) Antibody Manufacturer
Cyclin D1 4% BSA 135.0 [DCS-6] ab10540 Abcam, Cambridge, UK
Cyclin E 4% BSA 2.0 [E-4] SC-25303 Santa Cruz Biotechnology, Santa Cruz, CA, USA
Cyclin E 4% non fat milk 2.0 [M-20] SC-481 Santa Cruz Biotechnology, Santa Cruz, CA, USA
Cyclin A 4% BSA 0.5 [H-432] SC-751 Santa Cruz Biotechnology, Santa Cruz, CA, USA
Cdk2 4% non fat milk 0.03 [M2] SC-163 Santa Cruz Biotechnology, Santa Cruz, CA, USA
Actin 4% non fat milk 0.1 A2066 Sigma, St. Louis, MO, USA
p18-Cyclin E 4% non fat milk 2.0μg/mL [M-20] SC-481 Santa Cruz Biotechnology, Santa Cruz, CA, USA
Parp-1 4% non fat milk 0.034μg/mL #9542 Cell Signalling Technology, Danvers, MA, USA
cCasp-3 4% non fat milk 0.175 µg/mL #9662 Cell Signalling Technology, Danvers, MA, USA
doi: 10.1371/journal.pone.0079073.t002
Bilirubin and Cell Cycle in Rat Brain
PLOS ONE | www.plosone.org 3 November 2013 | Volume 8 | Issue 11 | e79073
5 % CO2, 90 % humidity. Experiments were performed at a
confluence of about 90 %.
Cerebellar Granular Cell Primary Cultures [50], were
obtained dissecting the cerebella from 6 P8 Wistar rats a
biological repetition (5 biological repetitions). Tissues were
collected at RT in BME (Invitrogen, Life Technologies
Corporation, Grand Island, NY) medium with 100 µg/mL
gentamycin (Sigma-Aldrich, St. Louis, MO, USA), After
trituration, the tissue was transferred into 10 mL of solution 1
(0.03 % MgSO4 and 3 mg/mL BSA in Krebs buffer: 124 mM
NaCl, 5.37 mM KCl, 1.01 mM NaH2PO4.H2O, 2.7 µM Phenol
Red, 25 mM Hepes, 14.5 mM D-glucose, pH 7.40) and
centrifuged at 200 g for 1 min. The pellet was resuspended in
10 mL of Solution 2 (0.03 % MgSO4, 3 mg/mL BSA and 0.12
mg/mL trypsin in Krebs buffer) and incubated at 37°C for 15
min with gentle agitation. Trypsin was inhibited by the addition
of 10 mL of Solution 3 (0.03 % MgSO4, 3 mg/mL BSA, 0.16
mg/mL trypsin inhibitor, 0.014 mg/mL DNase I in Krebs buffer),
and suspension centrifuged at 200 g for 1 min. After decanting
of the supernatant, 3 mL of Solution 4 (0.07 % MgSO4, 3
mg/mL BSA, 0.52 mg/mL trypsin inhibitor, 0.045 mg/mL DNase
I in Krebs buffer) were added, and cells gently separated by
pipetting through a sterile fire-polished glass Pasteur pipette.
After 4 % BSA gradient-separation (Gradient Solution: 4% BSA
in 0.06 % MgSO4, 0.001 % CaCl2, 3 mg/mL BSA in Krebs
buffer), 180 g for 5 min, the cell pellet was resuspended in 5
mL of Neuron Medium (BME, 10 % heat-inactivated FBS, 2
mM L-glutamine, 25 mM KCl, 10 mM Hepes, 44 mM NaHCO3,
100 µg/mL gentamycin, pH 7.40). Cells were seeded in 5
µg /mL poly-L-lysine (molecular weight 30,000-70,000) pre-
coated 6-well plate at the density of 1.5 x106 cells/well in
Neuron Medium, and incubated at 37°C, 5 % CO2, 90 %
humidity. After 24 h the medium was renewed with the addition
of cytosine-β-D-arabino-furanoside (Ara-C, 10 µM), to prevent
the growth of non-neuronal cells, and D-glucose (5.6 mM).
Where not differently indicated, reagent were from Sigma-
Aldrich, St. Louis, MO, USA.
Exposure of primary cell to bilirubin
Both cell types were exposed to 126 nM of free bilirubin (Bf).
This value of Bf was selected based on previous data from our
group [51–54] and, most importantly, because mimics the Bf
found in P9 jj Gunn rats [55–57]. 25 µM purified UCB [58],
dissolved in DMSO (vehicle) (Sigma-Aldrich, St. Louis, MO,
USA) was diluted in culturing medium, containing 10% FBS. Bf
concentration was assessed by peroxidase assay [59,60], and
cells exposed for two hours. Control cells were exposed to the
same DMSO amounts (0.5% final volume) needed to produce
the desired Bf.
Evaluation of bilirubin effects on cell cycle and
apoptosis
FACS analysis of cell cycle on primary cells harvested with
trypsin, was performed as described above for the in vivo
analysis. Apoptosis was evaluated by cCasp3 detection by
Western blot (see in vivo section).
Statistical analysis
Significant differences between genotypes were determined
by unpaired t-test using InStat 3.06 (GraphPad Software, San
Diego, CA, USA). Differences were considered statistically
significant at a p value lower than 0.05. All results were
expressed as mean ± S.D.
Results
Bilirubin content in plasma and cerebella
Hyperbilirubinemia develops spontaneously in Gunn rats,
due to the lack of efficient glucuronidation, resulting in marked
unconjugated hyperbilirubinemia. Total plasma bilirubin was
216.25 ± 23.92 μM in jj pups (Tbil) as compared to 6.94 ± 1.28
μM in non-jaundiced JJ controls (p < 0.001) (Figure 1A). The
unconjugated bilirubin (UCB) present in the circulation may
enter tissues, diffusing across cellular membranes and the
blood brain barrier, and accumulating in organs. In brain, this
leads to neurological damage. In jj Gunn rats, the
hyperbilirubinemia was associated with a 130 times higher
bilirubin cerebellar concentration in jj pups (5200 ± 1600 vs. 40
± 6 nM, jj vs. JJ rats, p < 0.001) (Figure 1B).
mRNA expression of cell cycle regulators
Selected Cyclins and cyclin-dependent kinase 2 (Cdk2)
expression was followed as markers of bilirubin influence on
the cell cycle, as previously reported by others [31–34]. The
expression of Cyclin D1 (the first cyclin to be induced,
regulating the G0 to S phase transition) and Cyclin A (S phase
transition) mRNA was reduced (20% and 15%, respectively) in
cerebella of jj rats, whereas Cyclin A1 and Cdk2 (forming active
complexes with the Cyclins here studied) mRNA levels were
comparable to controls. By contrast, the Cyclin E1 (G1 to S
phase) mRNA level was increased by 45% (p < 0.01) in
hyperbilirubinemic jj pups (Figure 2).
Protein expression of cell cycle regulators
Similarly, the selected Cyclins and Cdk2 protein expression
was evaluated. Figure 3A shows that the antibodies recognized
well-defined band(s) at the expected molecular weight(s) in rat
tissues (CycD1: 36 kDa; Cyclin A: 43.8 KDa and 29.6 KDa;
Cyclin A1: 47.7 KDa, and Cdk2: 33 kDa). In addition to the
expected Cyclin E band at 50 KDa (full length, FL), the E-4
antibody (N-terminal epitope) also detected the cleaved forms
of Cyclin E ranging from 49 to 34 KDa (low molecular weight
forms, LMW) [61,62].
Where the bands were quantified, a significant decrease in
the level of Cyclin D1 (15%; p < 0.05), Cyclin A1 (about 30%; p
< 0.01), and “43.8” and “29,6” Cyclin A rat isoforms (each about
20%; p < 0.05) were observed (Figure 3 B) in
hyperbilirubinemic rats. Similarly, the level of Cdk2 was
decreased by 25% (p < 0.001) in jj rats.
Total Cyclin E (FL plus LMW) detected by the E-4 antibody
was increased about 19% (p < 0.05) in jj animals, due entirely
to the increased amounts of the LMW cleaved forms of Cyclin
E; while the amount of the FL form (50 kDa) was unchanged.
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p18-Cyclin E protein expression and cParp-1 and active
Caspase3 analysis
Because the increased expression of Cyclin E was
unexpected and, apparently, opposite to the concept of cell
cycle arrest, we decided to better analyse its up-regulation. For
this reason, we used the M-20 antibody (C-terminal epitope)
which recognize the p18-Cyclin E proteolytic fragment (Figure
4A), with known pro-apoptotic properties [63–65]. As shown in
Figure 4B, the p18-Cyclin E level was increased by about 67%
(p < 0.05). In agreement, Parp and cleaved Parp-1 (cParp-1,
Figure 4A), a marker of early apoptosis [66,67], were
significantly increased in jj animals by 38% and 54%,
respectively (both p < 0.01) as compared to control (JJ)
animals (Figure 4B). Under standard Western blot conditions,
the protein expression of cCasp3 was only detectable in jj
animals (data not shown). In order to perform the
quantification, we obtained the signal by exposing the film
longer. Under these conditions, we observed a cCasp3 amount
double in hyperbilirubinemic pups vs. the JJ control (p < 0.01)
(Figure 4B).
Western blot analysis of cerebral cortex samples
Cerebral cortex samples were also studied as cortex
represents a CNS post-mitotic tissue with tissue UCB amount
similar to jj cerebellum [68]. Cdk2 was selected since
significantly down regulated while Cyclin E, Parp-1; cParp-1
and cCasp3 were up regulated in the jj cerebellum. When the
analysis was performed on cerebral cortex samples, the Cdk2,
Cyclin E and Parp-1 levels were similar in the two genotypes
(mean ± SD: Cdk2: JJ: 1.0 ± 0.07; jj: 0.96 ± 0.08; T.Test: 0.34;
Cyclin E: JJ: 1.0 ± 0.3; jj: 0.89 ± 0.6; T.Test: 0.5; Parp-1: JJ: 1.0
± 0.06; jj: 0.91 ± 0.12; T.Test: 0.17). Both cParp-1 / cCasp3
were not detectable neither in JJ or in jj Gunn rats cerebral
cortex (data not shown).
Figure 1.  Plasma total unconjugated bilirubin amounts, and tissue cerebellar unconjugated bilirubin concentration.  A)
plasma total unconjugated bilirubin amounts (Tbil) , and B) tissue unconjugated bilirubin concentrations (TUCB). □ Normal
homozygous JJ and ■ Hyperbilirubinemic homozygous jj Gunn rat. Data are expressed as mean ± SD. 6 animals of both genotypes
were used. Statistical significance: *** p < 0.001.
doi: 10.1371/journal.pone.0079073.g001
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FACS analysis of cell cycle
To confirm the cell cycle perturbation in vivo, we performed a
FACS analysis in the pool of dissociated cells from whole
cerebella (Figure 5 A). In cerebella from hyperbilirubinemic jj
animals as compared to cerebella from normobilirubinemic JJ
rats, the proportion of cells in G0/G1 phase was increased (p <
0.01), while that in S phase was decreased (p < 0.05). On the
contrary, the percentage of cells in the latest cell cycle phase
(G2/M) was identical in both genotypes.
By forward scattering analysis, two population, namely
population A and B, were detected (Figure 5 B). The cell cycle
in population A was comparable in the two genotypes, while in
population B, an increased presence of cells in G0/G1 phase (p
< 0.01) was observed, with a concomitant decrease in S phase
(p < 0.05), and G2/M phase (p < 0.01) (Figure 5 B). We did not
identify the two population by specific antibodies; most
probably because the dissociation procedure needed to obtain
Figure 2.  mRNA relative expression of Cyclin D1, Cyclin
E1, Cyclin A, A1 and Cdk2.  □ Normal homozygous JJ and ■
Hyperbilirubinemic homozygous jj Gunn rat. Data are
expressed as mean ± SD. Statistical significance: ** p < 0.01.
doi: 10.1371/journal.pone.0079073.g002
an optimal single cell suspension for FACS, disrupted the
epitopes.
In vitro analysis of bilirubin effects on the cell cycle
and apoptosis
To identify which proliferating cerebellar population (neuronal
or astroglial) was primarily affected by bilirubin, we used an in
vitro model of primary cultures of granular and astrocyte cells
obtained from Wistar rat cerebellum, and challenged the cells
with toxic concentration (126 nM) of free bilirubin.
By FCAS analysis, in granular cells we observed an
increased percentage of cells in Go/G1 phase (p < 0.01), with a
concomitant decrease in S and G2/M phases (p < 0.05 and p <
0.01, vs. vehicle alone, respectively). In astrocytes, a statistical
difference (p < 0.05) was observed only in phase S, while no
alterations of G0/G1 or G2/M phases were present (Figure 6
A).
Similarly, apoptosis, as evaluated by Caspase3 levels, was
increased only in granular cells exposed to bilirubin (p < 0.05),
while no changes were detectable in astrocytes.
Discussion
Despite several mechanism(s) of bilirubin toxicity to CNS
have been long proposed [20,22], the possibility that bilirubin
may alter the cell cycle has emerged only more recently
[31–35]. The proliferation of granular precursor cells in the
external granular layer is the dominant event in the rodent
cerebellar growth early after birth [38,39], rendering this
structure vulnerable to bilirubin toxicity and suggesting a link
between cell cycle perturbations and the typical cerebellar
hypoplasia of the jj Gunn rat [13].
By the use of this animal model, we report at P9 an
increased percentage of cells in late G0/G1 phase in the
cerebellum of hyperbilirubinemic (jj) Gunn rat pups. The
perturbation of the cell cycle was corroborated by the
decreased in vivo expression of Cylins D1, A, and A1 protein,
and of the constitutively expressed Cdk2. This was associated
with a 130 fold higher UCB concentration in the cerebellum of jj
pups, supporting the conclusion that high tissue concentration
of UCB we observed in vivo interferes with the cell cycle of
cerebellar cells, as previous reported in vitro for neurons [37]
and other cells type [31–34]. The cerebellum of rodents rapidly
develops early after birth, a period comparable to perinatal in
humans [38]. Although cerebellar hypoplasia in humans is not
usually reported, sporadically cases have been described [40],
and signs of functional and structural findings of cerebellar
bilirubin have been documented in humans [3,18,19]. This is
most probably due to the fact the human cerebellum develops
during the fetal life, and no mitotic cells are present after the
birth when the bilirubin level picks. This hypostesis is supported
by the lack of effects on both cell cycle and apoptosis in the
Gunn cerebral cortex, a post-natal post mitotic CNS structure,
having similar to cerebellum UCB content.
We observed a marked increase in Cyclin E mRNA and
protein in jj animals. This was apparently in contrast with the
concept that UCB arrests the cell cycle, and contrary to the
down-regulation of Cyclin E reported in vitro by Ollinger [31],
Bilirubin and Cell Cycle in Rat Brain
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Figure 3.  Representative Western blot and protein relative expression of Cyclin D1, Cyclin E, Cyclin A, A1 and Cdk2.  A)
Representative Western blot, and B) protein relative quantification. FL: full length Cyclin E (50 kDa), LWM: low molecular weight
Cyclin E forms (49-34 kDa), Total: FL plus LMW Cyclin E forms. □ Normal homozygous JJ and ■ Hyperbilirubinemic homozygous jj
Gunn rat. Data are expressed as mean ± SD. Statistical significance: * p < 0.05, ** p < 0.01, *** p < 0.001.
doi: 10.1371/journal.pone.0079073.g003
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Figure 4.  Representative Western blot and protein relative expression of p18-Cyclin E, Parp-1, cParp-1 and cCasp3.  A)
Representative Western blot, and B) protein relative quantification. cParp-1: cleaved Parp-1. cCasp3: active caspase3 □ Normal
homozygous JJ and ■ Hyperbilirubinemic homozygous jj Gunn rat. Data are expressed as mean ± SD. Statistical significance: * p <
0.05, ** p < 0.01.
doi: 10.1371/journal.pone.0079073.g004
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Figure 5.  Cell Cycle profile in JJ and jj P9 Gunn rats.  Cell cycle was analysed on cells from whole cerebella (A), and in
population A and B, identified by forward- scattering (B). □ Normal homozygous JJ and ■ Hyperbilirubinemic homozygous jj Gunn
rat. Data are expressed as mean ± SD. Statistical significance: * p < 0.05, ** p < 0.01.
doi: 10.1371/journal.pone.0079073.g005
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where primary cultures of vascular smooth muscle where
treated with up to 200 μM bilirubin/biliverdin. This apparent
disagreement may be justified by the relevant difference in
experimental model used. In fact, the in vivo data were
obtained on whole homogenates of P9 cerebella, an
experimental model more close to in vivo situation of severe
neonatal jaundice or Crigler-Najjar type I patients. The high
levels of the total Cyclin E protein are almost entirely
accounted by the increase in the LMW isoforms, whereas the
protein expression of the FL form was unchanged. The latter
result is in agreement with data reported by Peyton, where
local administration of bilirubin to injured rat carotid arteries did
not affect the Cyclin E FL protein amount [33]. Unfortunately,
no information was provided on the levels of Cyclin E cleaved
forms.
The complex of LMW Cyclin E with Cdk2 is known to be
functionally more active then FL Cyclin E/Cdk2 complex,
accelerating the cell cycle progression and proliferation [61,62],
Figure 6.  Effects of bilirubin on cell cycle and apoptosis in cerebellar granular and astrocytes primary cell cultures.  A)
Celll cycle analysis by FACS on cerebellar primary cell cultures exposed to 126 nM of Bf (black bars) and vehicle: 0.5% DMSO
(white bars). B) Western blot analysis of cCasp3 expression in astrocytes (grey bars) and granular cells (black bars) primary cell
cultures exposed to 126 nM of Bf vs. vehicle (0.5% DMSO, white bars). Data are expressed as mean ± SD. Statistical significance: *
p < 0.05, ** p < 0.01.
doi: 10.1371/journal.pone.0079073.g006
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and replacing Cyclin D1 deficiency [69]. However, this seems
not to be our case, as FACS analysis on cerebella of
hyperbilirubinemic pups confirmed a significant increase in the
G0/G1 cell populations with concomitant decrease of cells in S
phase. It is important to consider that the samples we analyzed
(Western blot, real time PCR, FACS) represent the entire pool
of cells that constitute the cerebellum, and include cells more
(neurones) and less (glial cells) sensitive to bilirubin toxicity
[70–73]. The presence of the less sensitive cells such as
population A in Figure 5 B, might partially mask the effect of
bilirubin toxicity to most sensible cells (population B, Figure 5
B), and minimize the difference between the two genotypes.
We reported a relevant increase (67%) for the p18-cyclin E
fragment in jaundiced jj Gunn rats. This fragment is generated
through caspase-mediated proteolytic cleavage of the C-
terminal portion of Cyclin E, abrogating its binding to Cdk2 and
consequent activation of Cyclin E activity [74]. Moreover, the
p18-cyclin E fragment has a critical role in the amplification of
the intrinsic apoptotic pathway by activating the caspase-
mediated apoptotic cell death [63,64]. This involves cleavage of
several proteins essential for cellular function and survival [75],
one of which is Parp-1, Poly (ADP-ribose) polymerase-1,
synthesized first and then cleaved (cParp, 85 kDa fragment) in
the early steps of apoptosis [66,67,76]. In line with this is the
increased level of cParp and cCasp3 in the cerebellum of P9
hyperbilirubinemic Gunn rat pups (Figure 4) indicating the
enhancement of the apoptotic process by the higher UCB
levels present in these jaundiced animals, as previously
demonstrated in in vitro by the exposure of rat neurons to UCB
[26]. Unfortunately, we were not able to identify the two
population by specific antibodies or primers, most probably
because the procedure we applied to obtain an optimal single
cell suspension to be assessed by FACS, was disruptive, when
we challenged primary neuronal and astrocytes cells with toxic
amounts of bilirubin, we confirmed the higher sensitivity to
bilirubin of neuronal granular cells as compared to astrocytes
(Figure 6). Moreover, we demonstrated that bilirubin is the toxic
compound for the perturbation of the cell cycle and apoptosis
only in the granular cells, pointing as cell population target of
bilirubin toxicity in vivo.
In conclusion, our data obtained in vivo and confirmed in
vitro indicate that the high level of UCB in the cerebellum of
jaundiced jj Gunn rats causes cell cycle perturbation and the
enhancement of apoptosis, that may account at least in part for
the characteristic cerebellar hypoplasia of these animals. Cell
cycle alteration and apoptosis appear to be intimately linked
through an increased expression of p18-Cyclin E. This
hypothesis is supported by the lack of effects in the cerebral
cortex, a post mitotic CNS structure, in spite of a similar to
cerebellum UCB content. Our data also show that cerebellar
neuronal granular cells are the principal target of bilirubin
neurotoxicity. Since these are the fist data collected in vivo,
they may be important in understanding the mechanisms of
bilirubin toxicity to the CNS in humans.
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